0 Speaker List
 Anand  Shah, M.D. Image

Anand Shah, M.D.

Deputy Commissioner for Medical and Scientific Affairs, Food and Drug Administration (2020-2021); Senior Medical Advisor, Centers for Medicare & Medicaid Services (2019-2020); Chief Medical Officer, Center for Medicare & Medicaid Innovation (2017-2019)

Fee Range:
Inquire for Details

Anand Shah, M.D. is a nationally recognized physician leader and health policy expert who most recently served as the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration. He provides insights on bringing new technologies to market, redesigning health care delivery and payment, and expanding competition and consumer choice. Dr. Shah has held successive senior leadership roles in U.S. health care which span discovery to delivery, centered at the nexus of life sciences and health services. Dr. Shah is widely published in leading scientific and national media outlets, and is highly sophisticated with effective public health communications. Dr. Shah continues to care for patients as an oncologist and clinical trialist.

Bio

Anand Shah, M.D. is a nationally recognized physician leader and health policy expert who most recently served as the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration. Dr. Shah led the agency’s operations as it relates to medical and scientific affairs. He was responsible for developing and leading high-priority policy in support of FDA’s public health mission. Dr. Shah represented FDA with top-level policy makers of the White House and Cabinet, Governors, and local governments. He regularly briefed bipartisan bicameral Congressional leadership on the formulation of public health policies and programs.

Dr. Shah’s efforts have focused on bringing new technologies to market, redesigning health care delivery and payment, and expanding competition and consumer choice. At FDA, he developed consensus policy on fit-for-purpose programs including Advanced Manufacturing, the Coronavirus Treatment Acceleration Program, COVID-19 vaccine development, digital health, consumer protection, and clinical trials. He developed a science and technology incubator designed to harness the power of real-world evidence and artificial intelligence to improve health outcomes.

He previously served in two senior leadership roles at the Centers for Medicare & Medicaid Services where he led the development of numerous market-driven, innovative policies and programs. As Senior Medical Advisor, he was the primary counselor for agency-wide policy related to medical and scientific innovation. Dr. Shah established consensus on several critical policy initiatives including aligning payment and prevention to increase Medicare beneficiaries’ access to novel antimicrobials, expanding patients’ access to new cell and gene therapies, and streamlining Medicare access to breakthrough technologies. As the Chief Medical Officer of the Center for Medicare & Medicaid Innovation, Dr. Shah led the clinical design of novel value-based payment and service delivery models including those for advanced primary care, specialty care, and prescription drugs.

Speech Topics

During the COVID-19 pandemic, Dr. Shah worked closely with industry, academic, and government leaders to develop strategies related to testing, therapeutics, and vaccines. He led the development of FDA’s COVID-19 Pandemic Recovery and Preparedness Plan. Dr. Shah contextualizes these experiences and discusses the importance of an integrated approach to early recognition and action, operations, crisis communications and policy, and preventing the next public health crisis. He educates leaders on the importance of using a structured approach to distilling lessons learned in order to inform future organizational strategic planning.


As a leading health care expert and oncologist caring for the elderly, Dr. Shah shares his experiences navigating and shaping primary and specialty care in America. He focuses his presentation on potential solutions to the problems Medicare beneficiaries encounter related to a fragmented health care system. Dr. Shah discusses in depth the critical political, economic, and data challenges in implementing meaningful health care reform. He discusses the impact of value-based care on the realignment of incentives for patients, providers, and payers.


Unprecedented advances in biomedical innovation such as precision medicine, cell and gene therapies, regenerative medicine, and artificial intelligence require new regulatory and health care delivery paradigms to sustain affordable access for patients and consumers. Dr. Shah discusses the latest trends and opportunities along the arc of innovation that spans from discovery and investment to delivery and payment. How do we bridge the valley that often stands between new medical products and their delivery to the patient’s bedside? What are new potential frameworks for health care that can ensure continued innovation, improve the quality of care, and decrease costs?


News